Multiparameter Flow Cytometry: An Important Auxiliary Tool for The Diagnosis and Differential Diagnosis of Myelodysplastic Neoplasms
Journal Title: Diseases & Research - Year 2023, Vol 3, Issue 1
Abstract
Multiparameter flow cytometry (MFC) shows promise in the diagnosis and differential diagnosis of myelodysplastic neoplasms (MDS). By identifying abnormal immunophenotypes of different cell lineages in bone marrow (BM) cells, MFC can aid in the differential diagnosis of some bone marrow failure diseases. Several flow cytometry scoring systems have been established based on current parameters, but there is still no specific immunophenotype available for the diagnosis of MDS. Morphological examination of cells remains the gold standard for MDS diagnosis. In the future, identifying specific cell immunophenotypes may improve MDS diagnosis and alter the use of MFC. MFC may also provide a solution for tracking the evolution of specific abnormal hematopoietic clones in MDS.
Authors and Affiliations
Siqi Luo, Rong Huang, Shifeng Lou
Bioinformatics Analysis to Screen the Key Genes and Pathways in the Formation of Early T-cell Precursor Acute Lymphoblastic Leukemia
Purpose Early T-cell precursor acute lymphoblastic leukemia (EPT-ALL) is a rare type of ALL that shows genetic characteristics of both ALL and acute myeloid leukemia (AML) but has a poorer prognosis and a higher recurren...
Incidence of Side Effects During Tenofovir Alafenamide Monotherapy in Patients with Chronic Hepatitis B
Objective Tenofovir alafenamide (TAF) is a new prodrug of tenofovir that is widely used in chronic hepatitis B (CHB) patients, and its side effects have rarely been reported. We aimed to evaluate the incidence of side ef...
Tumour Microenvironment in Therapy of Metastatic Cancer
GLOBOCAN 2020 has reported that the global cancer burden is 19.3 million cases, with 10 million deaths[1]. The overall survival (OS) after treatment with innovative cancer therapies has not changed for most metastatic ca...
Emergence, Mechanism of Action, Clinical Applications and Challenges of Nanomedicine for Tumor Therapy
With the increase in cancer cases globally, researchers have tried various methods to treat cancer. The study of nanomedicine, a novel drug form, has gained popularity in the medical community. Nanomedicine is a signific...
Clinical Study on Flumatinib Mesylate Combined with Chemotherapy Followed by Autologous Hematopoietic Cell Transplantation in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
Objective To investigate the clinical efficacy and safety of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) patients treated with second-generation tyrosine kinase inhibitor (TKI) flumatinib mesyl...